Development and validation of a bleeding risk prediction score for patients with mitral valve stenosis and atrial fibrillation or mechanical heart valves receiving long-term warfarin therapy.
Sararat PhetroongSurakit NathisuwanBusba ChindavijakArintaya PhrommintikulUbonwan SapooBancha SookananchaiWatcharapong PriksriGregory Y H LipPublished in: British journal of clinical pharmacology (2022)
The HEARTS-60 + 3 score shows a potential as a bleeding risk prediction score in MSAF or MHV patients.
Keyphrases
- atrial fibrillation
- mitral valve
- left atrial
- oral anticoagulants
- end stage renal disease
- direct oral anticoagulants
- catheter ablation
- left atrial appendage
- heart failure
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- aortic valve
- venous thromboembolism
- patient reported outcomes
- mesenchymal stem cells
- risk assessment
- patient reported
- aortic stenosis